Skip to main content
HLB INC. logo

HLB INC. — Investor Relations & Filings

Ticker · 028300 ISIN · KR7028300002 KO Manufacturing
Open in API
Filings indexed 553 across all filing types
Latest filing 2026-04-21 Major Shareholding Noti…
Country KR South Korea
Listing KO 028300

About HLB INC.

https://www.hlb.global/

HLB INC. is a biopharmaceutical company focused on developing new global anti-cancer drugs. The company's core activities center on advancing a pipeline of novel therapeutics through its worldwide network, which includes subsidiaries like Elevar Therapeutics and Immunomic Therapeutics. In addition to its primary focus on oncology, HLB's affiliated companies are involved in other life science areas, such as developing and manufacturing in vitro diagnostic medical devices, peptide-based biomaterials, and quasi-drugs. The group also has operations in composite materials and shipbuilding, reflecting its diversified origins.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a ‘주식등의 대량보유상황보고서’ – a mandatory disclosure of large shareholding under Korean Capital Markets law. It details the number of shares, ownership ratios, special relationships, and share‐related contracts by the major shareholder (진양곤) and affiliates. This matches the ‘Major Shareholding Notification’ category.
2026-04-21 Korean
전환가액의조정
Capital/Financing Update Classification · 1% confidence The document is a KRX-style regulatory disclosure detailing the adjustment of the conversion price for the company’s 39th tranche convertible bonds, including pre- and post-adjustment prices, calculation methodology, and effective dates. This is not an earnings, annual, or management report, nor a simple publication notice. Instead, it provides an update to the terms of the company’s capital structure (convertible bond financing). As such, it falls under Capital/Financing Update (CAP).
2026-04-16 Korean
증권발행결과(자율공시)
Capital/Financing Update Classification · 1% confidence The document is a voluntary disclosure of the result of a securities issuance (private placement convertible bonds) including terms, amounts, dates, and listing plans. This is a financing activity announcement (fundraising via convertible bonds), fitting the Capital/Financing Update category rather than a full report or share buyback.
2026-04-15 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a Korean "주요사항보고서" (Key Matters Report) filed with the Korean Financial Services Commission / Korea Exchange announcing the decision to issue convertible bonds (전환사채권 발행결정). It details the size, terms, interest, conversion mechanics, adjustment formulas, early redemption options, and specific allotments – all characteristic of a corporate financing transaction announcement. This is not an annual or interim financial report, nor a board change, proxy statement, or share repurchase; it is clearly a financing activity updating the market on a new debt instrument issuance. Therefore, it falls under Capital/Financing Update (CAP).
2026-04-07 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a public filing titled “사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고,” which details the appointment, dismissal, or resignation of outside directors and is submitted to the Financial Services Commission/Korea Exchange. This is clearly an announcement of changes in the board of directors, fitting the Board/Management Information category.
2026-03-31 Korean
대표이사변경
Board/Management Information Classification · 1% confidence The document is an official announcement detailing a change in the company’s representative director (CEO), including previous and new appointees, board resolution date, and related career details. This falls squarely under ‘Board/Management Information’ rather than a full report or other filing type.
2026-03-31 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.